November 14th, 2025: Three New Jersey Cases Added to Expanding GLP-1 Drug MDL A federal judicial panel has transferred three additional lawsuits from New Jersey into the growing multidistrict litigation involving claims that Eli Lilly and Novo Nordisk minimized the safety risks associated with GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Trulicity
By focusing on root-causes (nutrition, metabolism, digestion, activity) rather than purely symptom suppression, youre building a foundation for long-term health rather than short-term change
Even though you are having a complete diet, your body will be lacking essential vitamins to keep itself healthy particularly as we age
D.YounY
Some patients also explore advanced options like high dose vitamin C, alpha lipoic acid, NAD infusion therapy, ozone therapy, or oxygen treatment as part of a broader infusion plan
doi: 10.4093/dmj.2021.0314